Clinical Trials Browser

INDUSTRY × magrolimab × Plasma cell × Clear all

NCT04892446 2025-05-02

Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

36 enrolled 17 charts

Multiple Myeloma